Every SEC Form 3/4/5 on record for this filer (CIK 1708681) — 1 issuer, 28 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PUBLIC LTD CO | Chief Scientific Officer | 2017-06-13 → 2026-03-05 | 20 | −$8M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PRTA | 2023-08-02 | Sell | 3,771 | $66.98 | $252,582 | 229 |
| PRTA | 2023-08-02 | Sell | 229 | $68.07 | $15,588 | — |
| PRTA | 2023-07-05 | Sell | 2,991 | $67.98 | $203,328 | 1,009 |
| PRTA | 2023-07-05 | Sell | 1,009 | $68.69 | $69,308 | — |
| PRTA | 2023-06-07 | Sell | 294 | $73.14 | $21,503 | — |
| PRTA | 2023-06-07 | Sell | 2,943 | $70.02 | $206,069 | 16,057 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.